Cmed is highly experienced in the management of cell and gene therapy clinical trials, whether in oncology, rare diseases or other therapeutic areas.
- Complex Protocol Designs
- ATIMP Regulatory Processes
- Manufacturing & Logistics
- Data Availability & Technology
Cmed is the best choice to manage complex cell and gene therapy trials and has worked with multiple sponsors on treatments for oncology and rare diseases.
Our experience includes CAR-T cells, HSC, autologous Gamma-Delta T Lymphocytes, Adenovirus vector-based gene therapy etc.